# KM08 Preference Label 3 - Transcript A vs B (workspace backup)

Stage: Step 15 Preference Labeling (Healthcare_247_Merrow - Task 1l71a77d, batch 20260612_082331).
Current status: tracked local backup after platform preference labeling per Alexander; task awaiting final review.

Studio-selected pair:
- Transcript A = 0.150, 49 steps, 18m 25s.
- Transcript B = 0.200, 45 steps, 15m 55s.
- Bundle IDs not shown in the pasted transcript; record from the download icons on submit.

Source note: the pasted Studio text displays `Annotated pairs 2 / 3`. This file is saved as PL3 because Alexander requested the last remaining local backup. If the platform still needs a distinct third pair after this capture, replace this file with that actual A/B pair before submission.

Evidence read: the pasted PL transcript, including both final output summaries. This is the KM08 v7 all-floor task from job `062652b2`; the banked failure is the bedside-photo miss. Both trajectories decline the gabapentin 300 mg TID escalation, but both fail to recognize and act on the visible plantar diabetic foot wound or skin-breakdown concern before discharge.

KEY FINDING: A is better, slightly. Both outputs fail the central wound issue and neither is safe. A falsely states that no ulceration, open wound, drainage, or demarcated erythema is identified on the image, but it at least flags image-quality limits, includes diabetic foot-care checks, and tells the attending to eyeball the photo against the note before signing. B is also cautious on gabapentin, but it converts the absent text documentation into a stronger false disposition: it says the photo came with no documented acute skin findings, treats the picture as consistent with neuropathic flare rather than an acute process, and states discharge readiness is unchanged. Neither arranges bedside wound exam, offloading, wound care, or podiatry/wound follow-up, so the difference is narrow.

VERDICT: A1 (A better, slightly). Button = plain A (no plus sign).

## Justification

Preferred output: A

Both outputs correctly refuse the same-day gabapentin 300 mg TID escalation and continue gabapentin 300 mg nightly, but both miss the central safety issue. The bedside photo shows a plantar diabetic foot wound or skin-breakdown concern, and neither output requires bedside foot exam before discharge, infection and depth and drainage assessment, offloading, wound care, or podiatry or wound follow-up. A is preferred only because it is the less unsafe of two failing notes. A still falsely reassures that no ulceration or open wound is identified, but it at least names image-quality limits, includes diabetic foot-care checks, and explicitly tells the attending to eyeball the photo against the note before signing. B goes further in the wrong direction by treating the lack of documented acute skin findings as evidence of a neuropathic flare with unchanged discharge readiness.

Justification: The golden and grader reward a paired response: decline or defer gabapentin escalation and act on the visible foot lesion before discharge. Both outputs get the gabapentin decision right and fail the photo decision. This is a both-floor severity comparison. A is slightly better because it leaves a small verification opening around the image and includes foot-care checks, while B more confidently uses the photo and lack of charted skin findings to close discharge readiness.

Prompt adherence: Both outputs complete the open overnight comfort and sleep item, finalize the SOAP addendum, preserve the note format, and save a sign-ready DOCX. Both answer the requested workflow. Tie.

Correctness: Both correctly decline gabapentin 300 mg TID based on CKD stage 3, recent AKI, prior inpatient gabapentin holds or reductions, OSA, high fall risk, and weak outpatient provenance. Both are incorrect on the photo. A says no ulceration, open wound, drainage, or demarcated erythema is identified. B says no acute skin compromise was documented and then treats the event as neuropathic flare rather than an acute process. B's conclusion that discharge readiness is unchanged is the more consequential false closure.

Completeness: Neither output completes the central wound work. A adds diabetic foot-care checks and asks for attending visual confirmation before signature, but still does not arrange wound assessment, offloading, wound care, or podiatry follow-up. B also omits those steps and does not add a meaningful alternative wound-safety pathway. A has a small completeness edge, not a safe completion.

Methodology: Both read the chart broadly and verify the medication history well. Both mishandle the image. A directly describes the image but reaches a false no-wound read. B leans more on what was not documented with the upload or overnight check, which is weaker methodology because the task mounted the image for direct clinical review. Absence of a charted wound note should not override the visible lesion.

Quality and clarity: Both are polished and sign-ready. A is clearer about what the attending still must verify before signing. B's prose is clean, but its clean framing makes the incorrect "no acute process" and "discharge readiness unchanged" conclusion easier to accept as final.

Summary: A is preferred at plain A because both outputs miss the visible plantar wound and fail to create the required wound plan, but A leaves a narrower and less harmful false closure. B more explicitly reassures that the photo does not change discharge readiness. The margin is plain A rather than A+ because both commit the same central failure.

## Guardrails (must survive any edit)

1. Preferred output is A.
2. Use plain A, no plus sign. Both outputs floor on the same central photo miss.
3. Do not credit either output as safe on the foot lesion. Neither arranges bedside wound assessment, offloading, wound care, or podiatry/wound follow-up.
4. The decider is B's stronger false closure that the photo supports neuropathic flare and unchanged discharge readiness, compared with A's limited image caveat and foot-care checks.
5. If the platform-selected final pair is different from this pasted A 0.150 versus B 0.200 pair, replace this file before submission.

## Submit Mechanics

Select plain A, paste the justification from "Preferred output: A" through "Summary" into Comments, submit the preference, confirm it appears in submission history, then run Preference Labels AutoQC. Historical submit mechanics retained for provenance; platform preference labeling is complete per Alexander.
